C. Molinelli - Breast Unit, IRCCS Osped Policlin San Martino

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Navigating the Complexity of PI3K/AKT Pathway in HER-2 Negative Breast Cancer: Biomarkers and Beyond

M. Sirico,F. Jacobs,C. Molinelli,Guilherme Nader-Marta,V. Debien, H. Faith Dewhurst,M. Palleschi,F. Merloni,C. Gianni, U. De Giorgi, Evandro de Azambuja

Critical Reviews in Oncology/Hematology (2024): 104404-104404

引用0浏览0WOS引用

290P Subtype-specific Prognostic Value of Lobular Histology in Patients with Early-Stage Breast Cancer: A Nationwide Population-Based Study

G. Nader Marta, L. Ameye,D. Martins Branco,R.F. Salgado, N. Van Damme, J. Verbeeck,P.G. Aftimos,L. Buisseret, M. Paesmans,C. Molinelli, M. Lambertini,K. Van Baelen, C. Desmedt, M. Piccart,E. de Azambuja

Annals of Oncology (2024)

引用0浏览0引用

290P Adverse events (AEs) and impact on quality of life (QoL) of antibody-drug conjugates (ADC) in the treatment of metastatic breast cancer (mBC): A systematic review and meta-analysis of randomized controlled trials (RCTs)

M. Perachino,E. Blondeaux,C. Molinelli,T. Ruelle, I. Giannubilo,L. Arecco,S. Nardin,M.G. Razeti, R. Borea,D. Favero,C. Lanzavecchia, E. Chiappe, L.M. Tomasello,E. Mariamidze, K. Jankovic, M.M. Zahari,G. Scavone, S. Ottonello,C. Saura Manich,M. Lambertini

ESMO Open (2024)

引用0浏览0引用

Efficacy of Adjuvant Chemotherapy Schedules for Breast Cancer According to Body Mass Index: Results from the Phase III GIM2 Trial

F. Poggio,E. Blondeaux,M. Tagliamento,M. Perachino,S. Nardin, B. Conte,M. Giuliano,G. Arpino,M. De Laurentiis,A. Gravina,G. Bisagni,A. Rimanti,A. Turletti, C. Nistico, E. Magnolfi,S. Gasparro, A. Fabi,O. Garrone, M. G. Alicicco, Y. Urracci,P. Poletti, P. Correale,C. Molinelli,A. Fozza, F. Puglisi,G. Colantuoni,P. Fregatti, L. Boni, M. Lambertini, L. Del Mastro

ESMO OPENno. 8 (2024)

引用0浏览0WOS引用

125P Suboptimal ovarian suppression during adjuvant endocrine therapy for premenopausal women with breast cancer: An exploratory analysis of the PREFER and GIM 23 studies

S. Nardin,L. Del Mastro, I. Giannubilo,T. Ruelle,M.G. Razeti,L. Arecco, R. Borea,D. Favero,M. Perachino, E. Chiappe,C. Lanzavecchia, L. Barcellini, L.M. Tomasello,C. Molinelli,E. Blondeaux,M.M. Latocca,M. Lambertini,F. Poggio

ESMO Open (2024)

引用0浏览0引用

64P Baseline characteristics associated with Ki67 drop after neoadjuvant endocrine therapy in patients with HR+/HER2- early breast cancer: A systematic review

D. Martins Branco,C. Molinelli,G. Nader Marta,L. Ameye,M. Paesmans,R.F. Salgado,P.G. Aftimos,E. de Azambuja

ESMO Open（2023）

引用0浏览0引用

459P Progression-free Survival (PFS) Assessment by Local Investigators Versus Blinded Independent Central Review (BICR) in Randomized Clinical Trials (rcts) in Metastatic Breast Cancer (MBC): is It Really Needed

F. Jacobs,C. Molinelli,E. Agostinetto,D. Martins Branco,G. Nader Marta, M. Salmon,L. Ameye,M. Piccart,M. Lambertini,E. de Azambuja

Annals of Oncology (2023): S374-S374

引用0浏览0引用

228P The impact of initial tumor response to docetaxel, trastuzumab, and pertuzumab on survival outcomes of patients with HER2+ metastatic breast cancer: An exploratory analysis of the CLEOPATRA trial

V. Debien,E. Agostinetto,M. Bruzzone,M. Ceppi,C. Molinelli,D. Martins Branco,F. Jacobs,G. Nader Marta,M. Lambertini,E. de Azambuja

ESMO Openno. 1 (2023): 101417-101417

引用0浏览0引用

Prognostic Value of HER2-low Status in Breast Cancer: A Systematic Review and Metaanalysis

C. Molinelli,F. Jacobs,E. Agostinetto,G. Nader-Marta,M. Ceppi,M. Bruzzone,E. Blondeaux,F. Schettini,A. Prat,G. Viale,L. Del Mastro,M. Lambertini,E. de Azambuja

ESMO openno. 4 (2023): 101592-101592

引用2浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn